PGP and Stroke: However, for both stroke and major bleeding, estimates of RRs compared with warfarin were higher for patients with drugs affecting metabolism through CYP3A4 and P-gp than for patients without those drugs in the aggregated data and in separate analyses of apixaban and rivaroxaban.